Plasma Pharmacokinetics of Topical 0.1% Diclofenac Sodium and 0.5% Ketorolac Tromethamine in Dogs
Veterinary Ophthalmology · 2025
DOI: 10.1111/vop.70105 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary Ophthalmology, 2025. Verfasst von Jacqueline Peraza und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, Mississippi State University, Mississippi State, Mississippi, USA. Hauptthemen laut MEDLINE: Diclofenac, Ketorolac Tromethamine, Anti-Inflammatory Agents, Non-Steroidal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, Mississippi State University.
Abstract (Originalsprache)
Objective
To determine plasma concentrations of ophthalmic 0.1% (w/v) diclofenac sodium and 0.5% (w/v) ketorolac tromethamine following 4 times daily ophthalmic administration in healthy dogs. Animals Studied Eight healthy research Beagles. Procedures A prospective, masked, randomized, crossover study was conducted. Eight dogs were randomly assigned to a diclofenac or ketorolac group (4 dogs per group). Plasma was collected before drug administration (time 0/baseline). Each dog received 0.05 mL, equivalent to one drop of diclofenac or ketorolac into both eyes 4 times daily for 5 days (4 am, 8 am, 12 pm, and 4 pm). Plasma samples were collected at 5, 15, 30, 60, 120, 240, and 360 min after the 4 pm treatment on Days 1 and 5. Plasma concentrations (ng/mL) were quantified by liquid chromatography‐mass spectrometry and analyzed with noncompartmental pharmacokinetic analysis. A Wilcoxon signed rank test was used to determine statistical significance ( p < 0.05).
Results
After ophthalmic administration of 0.1% diclofenac, mean t 1/2 , T max , and C max occurred at 3.08 ± 0.9 h, 121.4 ± 2.8 h, 0.12 ± 0.05 μg/mL, respectively. The mean t 1/2 , T max , and C max after 0.5% ketorolac administration were 18.5 ± 14.6 h, 121.6 ± 2.0 h, 1.8 ± 1.7 μg/mL, respectively. The AUC 0‐∞ for diclofenac and ketorolac was 8.97 ± 3.73 μg/mL*h and 98.2 ± 43.3 μg/mL*h, respectively.
Conclusions
Diclofenac and ketorolac were rapidly absorbed systemically after ophthalmic administration. The half‐life of topical ketorolac is six times longer than that of diclofenac.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Sciences, Mississippi State University, Mississippi State, Mississippi, USA.
- Department of Comparative Biomedical Sciences, Mississippi State University, Mississippi State, Mississippi, USA.
ORCID-Profile: Caroline Betbeze
Förderung
- NIGMS NIH HHS
- Mississippi State University
Zitieren
APA
Peraza, J., Ross, M. K., Langston, V. C., Wills, R., Fischer, D., Cassen, C., & Betbeze, C. (2025). Plasma Pharmacokinetics of Topical 0.1% Diclofenac Sodium and 0.5% Ketorolac Tromethamine in Dogs. Veterinary Ophthalmology. https://doi.org/10.1111/vop.70105
Vancouver
Peraza J, Ross MK, Langston VC, Wills R, Fischer D, Cassen C, et al. Plasma Pharmacokinetics of Topical 0.1% Diclofenac Sodium and 0.5% Ketorolac Tromethamine in Dogs. Veterinary Ophthalmology. 2025. doi:10.1111/vop.70105
BibTeX
@article{Peraza2025,
author = {Peraza, Jacqueline and Ross, Matthew K and Langston, Vernon C and Wills, Robert and Fischer, Danielle and Cassen, Christine and Betbeze, Caroline},
title = {Plasma Pharmacokinetics of Topical 0.1% Diclofenac Sodium and 0.5% Ketorolac Tromethamine in Dogs},
journal = {Veterinary Ophthalmology},
year = {2025},
doi = {10.1111/vop.70105}
}
EUVIMED